Hospital
Saint Francis Hospital, INC.
Saint Francis Hospital, INC. was paid $43.14M by Medicaid between Jan 2018 and Dec 2024, across 147 billing codes. Its largest line is 99284, emergency room visit (serious) — 28% of everything it billed.
33Billing provider infoSAINT FRANCIS HOSPITAL, INC.
TULSA, OK 74136
TULSA, OK 74136
33aNPI1144228487assigned 07/11/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$43.14M
24GClaims548,396
24DCodes billed147
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Oklahoma
Rank by total paid#2 of 75
Median peer was paid$3.66M
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 72,782 | $5.42M | |
| 2019 | 72,490 | $5.92M | |
| 2020 | 55,022 | $4.10M | |
| 2021 | 76,397 | $6.24M | |
| 2022 | 99,456 | $7.79M | |
| 2023 | 119,286 | $9.27M | |
| 2024incomplete | 52,963 | $4.41M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 28% | 48,386 | 48,100 | $12.24M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 27% | 66,610 | 66,205 | $11.63M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.4% | 11,338 | 11,262 | $4.08M |
| J0791 | Injection, crizanlizumab-tmca, 5 mg | 5.8% | 774 | 568 | $2.50M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3.2% | 13,280 | 6,678 | $1.38M |
| D9999 | Unspecified adjunctive procedure, by report | 2.7% | 1,370 | 1,370 | $1.18M |
| 87631 | 2.6% | 8,926 | 8,906 | $1.11M | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2.1% | 15,318 | 15,262 | $922K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 1.5% | 882 | 882 | $634K |
| 80053 | Comprehensive metabolic panel | 1.4% | 50,004 | 43,670 | $606K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.3% | 1,185 | 1,185 | $567K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.1% | 13,162 | 4,544 | $462K |
135 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 57,856 | $395K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 1,844 | $383K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 55,759 | $372K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 9,731 | $370K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | <1% | 99 | $348K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,286 | $344K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 3,447 | $332K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 9,338 | $282K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 12,225 | $244K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,623 | $237K |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 627 | $222K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 2,366 | $190K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,471 | $132K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 720 | $123K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 8,494 | $119K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 1,838 | $115K |
| 71045 | Radiologic examination, chest; single view | <1% | 8,332 | $101K |
| 81001 | <1% | 16,716 | $78K | |
| 92526 | <1% | 1,008 | $75K | |
| 99205 | Prolong outpt/office vis | <1% | 451 | $70K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,360 | $65K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 10,521 | $63K |
| 83615 | <1% | 10,279 | $56K | |
| 84703 | <1% | 7,668 | $55K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 262 | $51K |
| 87486 | <1% | 1,617 | $50K | |
| 87581 | <1% | 1,617 | $49K | |
| 87807 | <1% | 4,066 | $48K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 858 | $47K |
| 84100 | <1% | 10,312 | $44K | |
| 84550 | <1% | 10,269 | $41K | |
| 83735 | <1% | 6,828 | $40K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 2,587 | $38K |
| 95886 | <1% | 460 | $36K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 714 | $35K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,487 | $34K |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,215 | $34K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 512 | $27K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 630 | $27K |
| 95819 | <1% | 97 | $26K | |
| 74019 | <1% | 1,200 | $24K | |
| 36430 | <1% | 149 | $22K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,998 | $22K |
| 82962 | <1% | 4,498 | $22K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 27 | $21K |
| 20680 | <1% | 13 | $21K | |
| 84484 | <1% | 1,942 | $20K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 228 | $18K |
| 83690 | <1% | 2,659 | $17K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 314 | $16K |
| 31624 | <1% | 14 | $15K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 146 | $14K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 111 | $13K |
| 73630 | <1% | 601 | $13K | |
| 76801 | <1% | 204 | $12K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 97 | $12K |
| 74230 | <1% | 135 | $11K | |
| 95816 | <1% | 49 | $11K | |
| 87430 | <1% | 722 | $10K | |
| 95910 | <1% | 199 | $8K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 14 | $8K |
| 95782 | <1% | 12 | $8K | |
| 95908 | <1% | 253 | $8K | |
| 87070 | <1% | 753 | $6K | |
| 99223 | Prolong inpt eval add15 m | <1% | 49 | $5K |
| 83880 | <1% | 169 | $5K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 72 | $5K |
| 96523 | <1% | 127 | $5K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 49 | $5K |
| 62323 | <1% | 12 | $4K | |
| 86140 | <1% | 981 | $4K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 528 | $4K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 53 | $4K |
| 85045 | <1% | 958 | $3K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 3,465 | $3K |
| 81025 | <1% | 373 | $3K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,724 | $2K |
| 88312 | <1% | 29 | $2K | |
| 80143 | <1% | 141 | $2K | |
| 80179 | <1% | 141 | $2K | |
| 82550 | <1% | 319 | $2K | |
| 82565 | <1% | 325 | $2K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 15 | $1K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,470 | $1K |
| 74018 | <1% | 88 | $1K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 12 | $1K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 12 | $1K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 83 | $1K |
| 99201 | <1% | 39 | $1K | |
| 88313 | <1% | 14 | $963.20 | |
| 82657 | <1% | 56 | $958.72 | |
| 87077 | <1% | 108 | $873.71 | |
| 91065 | <1% | 12 | $740.76 | |
| 82784 | <1% | 77 | $700.87 | |
| 88112 | <1% | 14 | $693.12 | |
| 83605 | <1% | 53 | $524.79 | |
| 93296 | <1% | 60 | $471.74 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,162 | $455.95 |
| 86850 | <1% | 45 | $384.49 | |
| 82728 | <1% | 34 | $363.60 | |
| 84466 | <1% | 33 | $329.15 | |
| 86901 | <1% | 114 | $287.02 | |
| 73090 | <1% | 12 | $273.60 | |
| 90688 | <1% | 16 | $267.60 | |
| 85060 | <1% | 12 | $264.72 | |
| 85652 | <1% | 84 | $196.80 | |
| 82800 | <1% | 18 | $176.04 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 6,282 | $167.97 |
| 83540 | <1% | 33 | $166.75 | |
| 86900 | <1% | 57 | $148.70 | |
| 80061 | Lipid panel | <1% | 15 | $133.30 |
| 87040 | <1% | 13 | $119.34 | |
| 87116 | <1% | 14 | $115.32 | |
| 87186 | <1% | 12 | $114.14 | |
| 85379 | <1% | 12 | $108.60 | |
| 87102 | <1% | 14 | $89.76 | |
| 36591 | <1% | 37 | $71.01 | |
| 87206 | <1% | 14 | $62.27 | |
| 85610 | <1% | 12 | $49.66 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 277 | $21.89 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 14 | $20.30 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 897 | $10.95 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 581 | $3.36 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 666 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 121 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 80 | $0.00 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 0% | 13 | $0.00 |
| C1889 | Implantable/insertable device, not otherwise classified | 0% | 121 | $0.00 |
| 96376 | 0% | 139 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 12 | $0.00 |
| 92611 | 0% | 126 | $0.00 | |
| J9260 | Injection, methotrexate sodium, 50 mg | 0% | 45 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 1,201 | $0.00 |
| 99152 | 0% | 80 | $0.00 | |
| J9370 | Vincristine sulfate, 1 mg | 0% | 187 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDAGE, DEBORAH (SENIOR VP, CFO)
| Provider | Location | Paid |
|---|---|---|
| Saint Francis Hospital Vinita, INC | Vinita, OK | $562K |
| Saint Francis Hospital Vinita, INC | Afton, OK | $444K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.